Rifencin Clear
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80073148
- Status
- Inactive licence
- Licence date
- 21 October 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcumine | 42 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Graine(s) Potency : 17.5 mg trans-Anethole | 25 mg | Not calculated |
Non-medicinal ingredients
Eau, Acide citrique, Glycérine, Poly(sorbate) 80, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to relieve digestive disturbances such as abdominal pain, abdominal distention and bloating.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have been diagnosed with estrogen dependent cancer or endometriosis or if you are currently taking Hormone Replacement Therapy.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you are allergic to anethole or plants of the Apiaceae/Carrot family.
Source
Official Health Canada record, licence 80073148
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.